Both the Winn Feline Foundation and the Morris Animal Foundation currently fund studies in Illinois to see if the human anti-diabetic drug,
pioglitazone, might help control (or perhaps, even
prevent) the progression of diabetes in cats as it apparently does in humans (ref).